Previous whole-exome sequencing (WES) and transcriptome sequencing of tumors identified multiple factors that are associated with favorable ICT outcome, including expression of PD-L11, high tumor mutational burden2, and the presence of tumor-infiltrating CD8+ T cells3. The gene discussed is CD8A; the disease is neoplasm.